These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 26496381)

  • 1. Getting it right: 3D cell cultures for the assessment of photosensitizers for photodynamic therapy.
    Senge MO; Stafford S
    Future Med Chem; 2015; 7(15):1957-60. PubMed ID: 26496381
    [No Abstract]   [Full Text] [Related]  

  • 2. Recent Advances in Developing Photosensitizers for Photodynamic Cancer Therapy.
    Chen C; Wang J; Li X; Liu X; Han X
    Comb Chem High Throughput Screen; 2017; 20(5):414-422. PubMed ID: 28088891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organic/inorganic nanohybrids rejuvenate photodynamic cancer therapy.
    Liang C; Zhang X; Wang Z; Wang W; Yang M; Dong X
    J Mater Chem B; 2020 Jun; 8(22):4748-4763. PubMed ID: 32129418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nature: a rich source for developing multifunctional agents. Tumor-imaging and photodynamic therapy.
    Pandey RK; Goswami LN; Chen Y; Gryshuk A; Missert JR; Oseroff A; Dougherty TJ
    Lasers Surg Med; 2006 Jun; 38(5):445-67. PubMed ID: 16788930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Light-enhanced hypoxia-responsive nanoparticles for deep tumor penetration and combined chemo-photodynamic therapy.
    Li Z; Wu M; Bai H; Liu X; Tang G
    Chem Commun (Camb); 2018 Nov; 54(93):13127-13130. PubMed ID: 30398488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strained ruthenium complexes are potent light-activated anticancer agents.
    Howerton BS; Heidary DK; Glazer EC
    J Am Chem Soc; 2012 May; 134(20):8324-7. PubMed ID: 22553960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of PDT photosensitizers with NO photodononors.
    Fraix A; Sortino S
    Photochem Photobiol Sci; 2018 Nov; 17(11):1709-1727. PubMed ID: 30141820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel strategy for targeting photodynamic therapy. Molecular combo of photodynamic agent zinc(II) phthalocyanine and small molecule target-based anticancer drug erlotinib.
    Zhang FL; Huang Q; Zheng K; Li J; Liu JY; Xue JP
    Chem Commun (Camb); 2013 Oct; 49(83):9570-2. PubMed ID: 24018863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current clinical and preclinical photosensitizers for use in photodynamic therapy.
    Detty MR; Gibson SL; Wagner SJ
    J Med Chem; 2004 Jul; 47(16):3897-915. PubMed ID: 15267226
    [No Abstract]   [Full Text] [Related]  

  • 10. Biophysical Characterization and Anticancer Activities of Photosensitive Phytoanthraquinones Represented by Hypericin and Its Model Compounds.
    Verebová V; Beneš J; Staničová J
    Molecules; 2020 Dec; 25(23):. PubMed ID: 33271809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive tutorial on in vitro characterization of new photosensitizers for photodynamic antitumor therapy and photodynamic inactivation of microorganisms.
    Kiesslich T; Gollmer A; Maisch T; Berneburg M; Plaetzer K
    Biomed Res Int; 2013; 2013():840417. PubMed ID: 23762860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Designing red-light-activated multifunctional agents for the photodynamic therapy.
    Higgins SL; Brewer KJ
    Angew Chem Int Ed Engl; 2012 Nov; 51(46):11420-2. PubMed ID: 23055391
    [No Abstract]   [Full Text] [Related]  

  • 13. Editorial: Throwing Light on Recent Advances on Metallodrugs: From Deemed Poisons to a Striking Hope for the Future.
    Nardon C; Fregona D
    Curr Med Chem; 2018 Feb; 25(4):434-436. PubMed ID: 29494325
    [No Abstract]   [Full Text] [Related]  

  • 14. Combining Inorganic Chemistry and Biology: The Underestimated Potential of Metal Complexes in Medicine.
    Karges J
    Chembiochem; 2020 Nov; 21(21):3044-3046. PubMed ID: 32896976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Porphyrin and nonporphyrin photosensitizers in oncology: preclinical and clinical advances in photodynamic therapy.
    O'Connor AE; Gallagher WM; Byrne AT
    Photochem Photobiol; 2009; 85(5):1053-74. PubMed ID: 19682322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel 3,6-bis(imidazolidine)acridines as effective photosensitizers for photodynamic therapy.
    Cižeková L; Grolmusová A; Ipóthová Z; Barbieriková Z; Brezová V; Hunáková L; Imrich J; Janovec L; Dovinová I; Paulíková H
    Bioorg Med Chem; 2014 Sep; 22(17):4684-93. PubMed ID: 25096820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent strategies to improve boron dipyrromethene (BODIPY) for photodynamic cancer therapy: an updated review.
    Kue CS; Ng SY; Voon SH; Kamkaew A; Chung LY; Kiew LV; Lee HB
    Photochem Photobiol Sci; 2018 Nov; 17(11):1691-1708. PubMed ID: 29845993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Near-IR absorbing BODIPY derivatives as glutathione-activated photosensitizers for selective photodynamic action.
    Turan IS; Cakmak FP; Yildirim DC; Cetin-Atalay R; Akkaya EU
    Chemistry; 2014 Dec; 20(49):16088-92. PubMed ID: 25345802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aminosquaraines as potential photodynamic agents: Synthesis and evaluation of in vitro cytotoxicity.
    Magalhães ÁF; Graça VC; Calhelha RC; Ferreira ICFR; Santos PF
    Bioorg Med Chem Lett; 2017 Sep; 27(18):4467-4470. PubMed ID: 28807437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current status of liposomal porphyrinoid photosensitizers.
    Skupin-Mrugalska P; Piskorz J; Goslinski T; Mielcarek J; Konopka K; Düzgüneş N
    Drug Discov Today; 2013 Aug; 18(15-16):776-84. PubMed ID: 23591149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.